This application is a competitive renewal for a Multidisciplinary Training Program in Lung Disease. Its goal is to provide training in basic and clinical sciences relevant to the study of pulmonary disease. The program proposes to support 12 postdoctoral fellows (M.D.s and Ph.D.s) per year. The focus of the training program is a two year experience in the laboratory under the close supervision of a faculty trainer, utilizing molecular, cellular, animal modeling, epidemiologic, or clinical approaches. The program utilizes faculty trainers from the Departments of Internal Medicine (Divisions of Pulmonary/Critical Care Medicine and General Medicine), Pediatrics (Hematology/Oncology), Pathology, and Radiology. The program also utilizes faculty trainers form the Departments of Epidemiology and Biostatistics at the University of Michigan School of Public Health. Faculty trainers either have extensive research experience in diverse, but interrelated areas of cellular and molecular biology or in biostatistics, epidemiology, clinical research design or medical economics. All faculty trainers have trained postdoctoral fellows who have subsequently gone on to independent, productive careers in research and teaching. New facilities and faculty have been incorporated into this program to offer outstanding training opportunities in the disciplines of modern biology and the disciplines relevant to rigorous clinical research. The program provides a structured curriculum that contains appropriate course work, exposure to relevant lecture series, and an in depth intensive laboratory and/or clinical research experience. A broad range of research topics is available to trainees, including chemokine biology, the pathobiology of fibrotic lung disease, host defense mechanisms, lymphocyte-macrophage interactions, epithelial cell biology, fibroblast biology, protease biology, arachidonic acid biochemistry, granulocyte biology, pulmonary epidemiology, molecular genetic studies of candidate genes influencing susceptibility to lung disease, outcomes in lung disease, quality improvement, physician decision making, economic assessment of medical interventions, appropriate utilization of medical technology, financing and organization of medical care, medical ethics, and medical education. Continuation of this training grant in lung disease at the University of Michigan will capitalize on the exceptionally strong resources that have been assembled at this institution. The program, as constructed, will produce a cadre of well-trained investigators devoted to understanding the pathogenesis and treatment of pulmonary diseases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007749-14
Application #
7082836
Study Section
Special Emphasis Panel (ZHL1-CSR-M (F1))
Program Officer
Colombini-Hatch, Sandra
Project Start
1993-07-01
Project End
2008-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
14
Fiscal Year
2006
Total Cost
$764,505
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Vasilevskis, Eduard E; Chandrasekhar, Rameela; Holtze, Colin H et al. (2018) The Cost of ICU Delirium and Coma in the Intensive Care Unit Patient. Med Care 56:890-897
Penke, Loka R; Speth, Jennifer M; Dommeti, Vijaya L et al. (2018) FOXM1 is a critical driver of lung fibroblast activation and fibrogenesis. J Clin Invest 128:2389-2405
Labaki, Wassim W; Han, MeiLan K (2018) Artificial Intelligence and Chest Imaging. Will Deep Learning Make Us Smarter? Am J Respir Crit Care Med 197:148-150
Admon, Andrew J; Gupta, Ashwin; Williams, Margaret et al. (2018) Appraising the Evidence Supporting Choosing Wisely® Recommendations. J Hosp Med 13:688-691
Govindan, Sushant; Snyder, Ashley; Flanders, Scott A et al. (2018) Peripherally Inserted Central Catheters in the ICU: A Retrospective Study of Adult Medical Patients in 52 Hospitals. Crit Care Med 46:e1136-e1144
Salisbury, Margaret L; Myers, Jeffrey L; Belloli, Elizabeth A et al. (2018) Reply to Fernández Pérez: Diagnostic Decision-Making in Hypersensitivity Pneumonitis: Toward a Consensus Statement. Am J Respir Crit Care Med 197:1647-1648
Kim, Lisa Ha-Yeon; Plaza, Karin; Thomas, Sruthi R et al. (2018) Endogenous peroxidases in sputum interfere with horse-radish peroxidase-based ELISAs. J Immunol Methods 454:76-79
Salisbury, Margaret L; Gu, Tian; Murray, Susan et al. (2018) Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory. Chest :
Viglianti, Elizabeth M; Kramer, Rachel; Admon, Andrew J et al. (2018) Late organ failures in patients with prolonged intensive care unit stays. J Crit Care 46:55-57
Govindan, Sushant; Wallace, Beth; Iwashyna, Theodore J et al. (2018) Do Experts Understand Performance Measures? A Mixed-Methods Study of Infection Preventionists. Infect Control Hosp Epidemiol 39:71-76

Showing the most recent 10 out of 291 publications